W-Shaped Acetabular Angular Plate (WAAP) Versus Reconstruction Plate
Launched by HEBEI MEDICAL UNIVERSITY THIRD HOSPITAL · Dec 25, 2014
Trial Information
Current as of May 19, 2025
Unknown status
Keywords
ClinConnect Summary
The posterior acetabular wall fracture is one of the simpler acetabular fracture patterns and the most common type, accounting for approximately one quarter of all acetabular fractures. Most patients achieve excellent outcomes after anatomical reduction and rigid internal fixation with standard screws and buttress plates.However,it is well known that the reconstruction plate need remould in the surgery. So it does not only lead to the extension of operation time, but also cause poor attach of acetabular posterior wall. Moreover, the angulation of the screw placement for the holes of the rec...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male or female aged 18 years or older(with no upper age limit)
- • Sustained a posterior acetabular wall fracture(ASIF/OTA classification 62-A1)
- • Operation was performed within 14 days after the fracture occurring
- Exclusion Criteria:
- • Presented with a pathologic acetabular fracture
- • Neuropathic arthropathy,dementia and other disease processes which made postoperative compliance unreliable
- • Refused to participate
- • Patients who were unable to walk before injury
About Hebei Medical University Third Hospital
Hebei Medical University Third Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient care. As a prominent clinical trial sponsor, the hospital focuses on innovative therapies and evidence-based practices across various medical fields. With a commitment to ethical standards and patient safety, the institution collaborates with multidisciplinary teams to conduct rigorous clinical studies that contribute to the scientific community and enhance treatment options. Leveraging state-of-the-art facilities and a patient-centric approach, Hebei Medical University Third Hospital plays a vital role in the advancement of clinical research and the development of new healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Shijiazhuang, Hebei, China
Patients applied
Trial Officials
Zhiyong Hou, MD
Study Chair
Hebei Medical University Third Hospital
Shuai Shang, MM
Principal Investigator
Hebei Medical University Third Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials